Characterization of Salvia Miltiorrhiza ethanol extract as an anti-osteoporotic agent

BMC Complementary and Alternative Medicine

Volumn 11, Issue , 2011, Pages

  Cui, Yan ^a   Bhandary, Bidur ^a   Marahatta, Anu ^a   Lee, Geum Hwa ^b   Li, Bo ^a   Kim, Do Sung ^a   Chae, Soo Wan ^a   Kim, Hyung Ryong ^b   Chae, Han Jung ^a  

^a Chonbuk National University   (South Korea)

^b Wonkwang University School of Medicine   (South Korea)

Author keywords

BMD; Morphometry; OVX; Oxidative stress; Salvia miltiorrhiza

Indexed keywords

CALCITONIN; CALCIUM; LIOTHYRONINE; MALONALDEHYDE; NITRIC OXIDE; OSTEOCALCIN; PARATHYROID HORMONE; SALVIA MILTIORRHIZA EXTRACT; ANTIOXIDANT; BONE DENSITY CONSERVATION AGENT; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MASS; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG ISOLATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; LIOTHYRONINE BLOOD LEVEL; LIVER; NONHUMAN; OSTEOPOROSIS; OXIDATIVE STRESS; PARATHYROID HORMONE BLOOD LEVEL; RAT; TIBIA; TRABECULAR BONE; ANIMAL; BLOOD; DRUG EFFECT; HISTOLOGY; HUMAN; METABOLISM; OSTEOCLAST; OVARIECTOMY; PHYTOTHERAPY; POSTMENOPAUSE OSTEOPOROSIS; RADIOGRAPHY; SALVIA MILTIORRHIZA; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; MALONDIALDEHYDE; NITRIC OXIDE; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL; OVARIECTOMY; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; TIBIA;

EID: 82155187077     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/1472-6882-11-120     Document Type: Article

References (32)

1. Anon. Osteoporosis prevention, diagnosis, and therapy. Jama 2001, 285:785-795. 10.1001/jama.285.6.785, 11176917, Anon..
2. Vassilopoulou-Sellin R. Breast cancer and hormonal replacement therapy. Ann N Y Acad Sci 2003, 997:341-350. 10.1196/annals.1290.037, 14644841.
3. Wang X, Morris-Natschke SL, Lee KH. New developments in the chemistry and biology of the bioactive constituents of Tanshen. Med Res Rev 2007, 27:133-148. 10.1002/med.20077, 16888751.
4. Han JY, Fan JY, Horie Y, Miura S, Cui DH, Ishii H, Hibi T, Tsuneki H, Kimura I. Ameliorating effects of compounds derived from Salvia miltiorrhiza root extract on microcirculatory disturbance and target organ injury by ischemia and reperfusion. Pharmacol Ther 2008, 117:280-295. 10.1016/j.pharmthera.2007.09.008, 18048101.
5. Zhou L, Zuo Z, Chow MS. Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 2005, 45:1345-1359. 10.1177/0091270005282630, 16291709.
6. Zhu YZ, Huang SH, Tan BK, Sun J, Whiteman M, Zhu YC. Antioxidants in Chinese herbal medicines: a biochemical perspective. Nat Prod Rep 2004, 21:478-489. 10.1039/b304821g, 15282631.
7. Kim HH, Kim JH, Kwak HB, Huang H, Han SH, Ha H, Lee SW, Woo ER, Lee ZH. Inhibition of osteoclast differentiation and bone resorption by tanshinone IIA isolated from Salvia miltiorrhiza Bunge. Biochem Pharmacol 2004, 67:1647-1656. 10.1016/j.bcp.2003.12.031, 15081864.
8. Zhang Y, Akao T, Nakamura N, Duan CL, Hattori M, Yang XW, Liu JX. Extremely low bioavailability of magnesium lithospermate B, an active component from Salvia miltiorrhiza in rat. Planta Med 2004, 70:138-142.
9. Lay IS, Chiu JH, Shiao MS, Lui WY, Wu CW. Crude extract of Salvia miltiorrhiza and salvianolic acid B enhance in vitro angiogenesis in murine SVR endothelial cell line. Planta Med 2003, 69:26-32. 10.1055/s-2003-37034, 12567275.
10. Wong RW, Rabie AB. Effect of Salvia miltiorrhiza extract on bone formation. J Biomed Mater Res A 2008, 85:506-512.
11. Ding Y, Soma S, Takano-Yamamoto T, Matsumoto S, Sakuda M. Effects of salvia miltiorrhiza bunge (SMB) on MC3T3-E1 cells. J Osaka Univ Dent Sch 1995, 35:21-27.
12. Chae HJ, Chae SW, Yun DH, Keum KS, Yoo SK, Kim HR. Prevention of bone loss in ovariectomized rats: the effect of Salvia miltiorrhiza extracts. Immunopharmacol Immunotoxicol 2004, 26:135-144. 10.1081/IPH-120029951, 15106738.
13. Brouwers JE, Lambers FM, Gasser JA, van Rietbergen B, Huiskes R. Bone degeneration and recovery after early and late bisphosphonate treatment of ovariectomized wistar rats assessed by in vivo micro-computed tomography. Calcif Tissue Int 2008, 82:202-211. 10.1007/s00223-007-9084-3, 2268729, 18286219.
14. Jiang SD, Shen C, Jiang LS, Dai LY. Differences of bone mass and bone structure in osteopenic rat models caused by spinal cord injury and ovariectomy. Osteoporos Int 2007, 18:743-750. 10.1007/s00198-006-0299-3, 17216554.
15. Kim DS, Han SH, Lee YC, Park SJ, Yoo WH, Kim HR, Chae HJ. The study of the combination of Slavia Miltiorrhiza and Kitosan on osteoporosis in ovariectomized rats. Kor J Clin Pharm 2009, 19(2):75-80.
16. Jarvinen TL, Sievanen H, Kannus P, Jarvinen M. Dual-energy X-ray absorptiometry in predicting mechanical characteristics of rat femur. Bone 1998, 22:551-558. 10.1016/S8756-3282(98)00025-8, 9600791.
17. Gothe S, Wang Z, Ng L, Kindblom JM, Barros AC, Ohlsson C, Vennström B, Forrest D. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 1999, 13:1329-1341. 10.1101/gad.13.10.1329, 316730, 10346821.
18. Kannus P, Jarvinen TL, Sievanen H, Kvist M, Rauhaniemi J, Maunu VM, Hurme T, Jozsa L, Järvinen M. Effects of immobilization, three forms of remobilization, and subsequent deconditioning on bone mineral content and density in rat femora. J Bone Miner Res 1996, 11:1339-1346.
19. Kastl S, Sommer T, Klein P, Hohenberger W, Engelke K. Accuracy and precision of bone mineral density and bone mineral content in excised rat humeri using fan beam dual-energy X-ray absorptiometry. Bone 2002, 30:243-246. 10.1016/S8756-3282(01)00641-X, 11792592.
20. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 1990, 186:421-431.
21. Bories PN, Bories C. Nitrate determination in biological fluids by an enzymatic one-step assay with nitrate reductase. Clin Chem 1995, 41:904-907.
22. Cremers S, Garnero P. Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls. Drugs 2006, 66:2031-2058. 10.2165/00003495-200666160-00001, 17112299.
23. Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Vaananen HK. Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab 2006, 52:499-509.
24. Kireev RA, Tresguerres AC, Garcia C, Borras C, Ariznavarreta C, Vara E, Vina J, Tresguerres JA. Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology 2010, 11:229-243. 10.1007/s10522-009-9242-2, 19633997.
25. Van't Hof RJ, Ralston SH. Nitric oxide and bone. Immunology 2001, 103:255 261. 1783253, 11454054.
26. Sánchez-Rodríguez MA, Ruiz-Ramos M, Correa-Muñoz E, Mendoza-Núñez VM. Oxidative stress as a risk factor for osteoporosis in elderly Mexicans as characterized by antioxidant enzymes. BMC Musculoskelet Disord 2007, 19(8):124.
27. Koh JM, Lee YS, Kim YS, Kim DJ, Kim HH, Park JY, Lee KU, Kim GS. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res 2006, 21(7):1003-11. 10.1359/jbmr.060406, 16813521.
28. Farley JR, Chesnut CH, Baylink DJ. Improved method for quantitative determination in serum of alkaline phosphatase of skeletal origin. Clin Chem 1981, 27:2002-2007.
29. Mosekilde L, Eriksen EF, Charles P. Effects of thyroid hormones on bone and mineral metabolism. Endocrinol Metab Clin North Am 1990, 19:35-63.
30. Mosekilde L, Melsen F, Bagger JP, Myhre-Jensen O, Schwartz Sorensen N. Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh) 1977, 85:515-525.
31. Madsen JE, Aune AK, Falch JA, Hukkanen M, Konttinen YT, Santavirta S, Nordsletten L. Neural involvement in post-traumatic osteopenia: an experimental study in the rat. Bone 1996, 18:411-416. 10.1016/8756-3282(96)00027-0, 8739898.
32. Nilas L, Christiansen C. Rates of bone loss in normal women: evidence of accelerated trabecular bone loss after the menopause. Eur J Clin Invest 1988, 18:529-534. 10.1111/j.1365-2362.1988.tb01052.x, 3147906.